FDA proposes cutting off affordable GLP-1 access for millions
A move by the U.S. Food and Drug Administration could significantly change how millions of Americans access some of the most widely used weight loss medications on the market. On April 30, the FDA announced a proposal to remove glucagon-like peptide-1 (GLP-1) receptor agonists including semaglutide and tirzepatide, the active ingredients in Ozempic, Wegovy and […]
How cigarette smoking increases your risk of heart attacks
Cigarette smoking is a prevalent habit that poses numerous health risks, particularly to the cardiovascular system. Among the most severe consequences of smoking is the increased risk of heart attacks. Understanding the mechanisms by which smoking affects the heart and blood vessels is crucial for both prevention and education. This article explores the intricate relationship […]